UBS ASSET MANAGEMENT AMERICAS LLC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 249 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is 2.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$11,579,696
+268.6%
114,821
+279.6%
0.01%
+150.0%
Q2 2023$3,141,6600.0%30,2490.0%0.00%0.0%
Q1 2023$3,141,660
+15.0%
30,249
-1.9%
0.00%
+100.0%
Q4 2022$2,732,505
-99.9%
30,8270.0%0.00%0.0%
Q3 2022$2,471,400,000
-23.6%
30,827
-8.8%
0.00%
-50.0%
Q2 2022$3,235,155,000
-36.0%
33,784
-0.8%
0.00%0.0%
Q1 2022$5,057,384,000
+6.7%
34,045
+1.8%
0.00%0.0%
Q4 2021$4,739,887,000
+6.8%
33,436
-1.4%
0.00%0.0%
Q3 2021$4,438,670,000
-6.0%
33,927
-1.3%
0.00%0.0%
Q2 2021$4,722,096,000
+4.7%
34,360
-0.5%
0.00%0.0%
Q1 2021$4,508,490,000
+17.1%
34,524
+0.5%
0.00%0.0%
Q4 2020$3,849,328,000
+38.6%
34,369
-2.6%
0.00%
+100.0%
Q3 2020$2,777,129,000
+22.5%
35,301
+12.1%
0.00%0.0%
Q2 2020$2,267,541,000
+17.1%
31,498
-6.8%
0.00%0.0%
Q1 2020$1,936,185,000
-50.1%
33,808
-2.5%
0.00%
-50.0%
Q4 2019$3,877,034,000
+17.7%
34,669
+1.2%
0.00%0.0%
Q3 2019$3,293,331,000
+40.0%
34,252
+24.6%
0.00%0.0%
Q2 2019$2,352,234,000
+33.0%
27,489
+29.3%
0.00%
+100.0%
Q1 2019$1,767,992,000
+42.1%
21,255
+9.7%
0.00%0.0%
Q4 2018$1,243,811,000
-15.6%
19,374
+4.1%
0.00%0.0%
Q3 2018$1,473,809,000
+8.4%
18,604
+0.2%
0.00%0.0%
Q2 2018$1,359,397,000
+21.8%
18,571
+5.4%
0.00%0.0%
Q1 2018$1,116,065,000
+73.0%
17,623
+39.2%
0.00%0.0%
Q4 2017$645,280,000
-2.9%
12,6600.0%0.00%0.0%
Q3 2017$664,271,000
+3.9%
12,660
+0.8%
0.00%0.0%
Q2 2017$639,602,000
+14.8%
12,556
+0.1%
0.00%0.0%
Q1 2017$557,035,000
+164217.1%
12,543
+63.2%
0.00%
Q4 2016$339,000
-48.1%
7,684
-52.9%
0.00%
-100.0%
Q3 2016$653,000
-16.1%
16,2990.0%0.00%0.0%
Q2 2016$778,000
+13.7%
16,2990.0%0.00%0.0%
Q1 2016$684,000
-10.7%
16,299
-6.3%
0.00%0.0%
Q4 2015$766,000
-7.8%
17,3990.0%0.00%0.0%
Q3 2015$831,000
-18.0%
17,3990.0%0.00%0.0%
Q2 2015$1,014,000
+27.9%
17,399
+10.8%
0.00%0.0%
Q1 2015$793,000
+14.6%
15,699
+1.9%
0.00%0.0%
Q4 2014$692,000
+22.0%
15,3990.0%0.00%0.0%
Q3 2014$567,000
-16.6%
15,3990.0%0.00%0.0%
Q2 2014$680,000
+7.3%
15,399
+5.5%
0.00%0.0%
Q1 2014$634,000
+28.6%
14,599
+25.9%
0.00%0.0%
Q4 2013$493,000
+17.1%
11,599
-6.5%
0.00%0.0%
Q3 2013$421,000
+8.8%
12,3990.0%0.00%
Q2 2013$387,00012,3990.00%
Other shareholders
CONMED CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders